eC-SSRS Solution from ERT Facilitates Compliance with New FDA Guidance

ERT ERES announced that its eC-SSRS solution facilitates compliance with the newly introduced Food and Drug Administration guidance document entitled "Suicidality: Prospective Assessment of Occurrence in Clinical Trials." A copy of this guidance can be downloaded from www.ert.com.